18182111

Source:http://linkedlifedata.com/resource/pubmed/id/18182111

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017337, umls-concept:C0017428, umls-concept:C0205281, umls-concept:C0677886, umls-concept:C0750502, umls-concept:C1414313, umls-concept:C1709707, umls-concept:C1879547
pubmed:dateCreated	2008-3-11
pubmed:abstractText	The status of the EGFR and HER2-neu genes has not been fully defined in ovarian cancer. An integrated analysis of both genes could help define the proportion of patients that would potentially benefit from targeted therapies.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-10711495, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-11571750, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-11775453, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-12525520, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-1423308, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15118073, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15118125, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15226774, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15284455, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15457249, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15571614, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15753357, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15782071, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15832190, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15863375, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15870435, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15934521, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-15998906, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16014882, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16020953, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16051667, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16061871, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16282176, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16336755, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16361548, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16554736, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16607561, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16672372, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16683254, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16753589, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-16785471, http://linkedlifedata.com/resource/pubmed/commentcorrection/18182111-17309668
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100967800
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status	MEDLINE
pubmed:issn	1471-2407
pubmed:author	pubmed-author:BourgainClaireC, pubmed-author:De GrèveJacquesJ, pubmed-author:GhislainVanessaV, pubmed-author:NeynsBartB, pubmed-author:TeugelsErikE, pubmed-author:VermeijJoannaJ, pubmed-author:XiangmingJiJ, pubmed-author:in 't VeldPeterP
pubmed:issnType	Electronic
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	3
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:18182111-Aged, pubmed-meshheading:18182111-Belgium, pubmed-meshheading:18182111-Biopsy, Needle, pubmed-meshheading:18182111-Carcinoma, pubmed-meshheading:18182111-DNA Mutational Analysis, pubmed-meshheading:18182111-Disease Progression, pubmed-meshheading:18182111-Female, pubmed-meshheading:18182111-Gene Expression Regulation, Neoplastic, pubmed-meshheading:18182111-Genes, erbB-1, pubmed-meshheading:18182111-Genes, erbB-2, pubmed-meshheading:18182111-Genomics, pubmed-meshheading:18182111-Humans, pubmed-meshheading:18182111-Immunohistochemistry, pubmed-meshheading:18182111-In Situ Hybridization, Fluorescence, pubmed-meshheading:18182111-Middle Aged, pubmed-meshheading:18182111-Neoplasm Invasiveness, pubmed-meshheading:18182111-Ovarian Neoplasms, pubmed-meshheading:18182111-Predictive Value of Tests, pubmed-meshheading:18182111-Probability, pubmed-meshheading:18182111-Prognosis, pubmed-meshheading:18182111-Retrospective Studies, pubmed-meshheading:18182111-Risk Assessment, pubmed-meshheading:18182111-Sampling Studies, pubmed-meshheading:18182111-Sensitivity and Specificity, pubmed-meshheading:18182111-Survival Analysis, pubmed-meshheading:18182111-Tumor Markers, Biological
pubmed:year	2008
pubmed:articleTitle	Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers.
pubmed:affiliation	Laboratory for Molecular Oncology, Universitair Ziekenhuis, Vrije Universiteit Brussel, 1090 Brussels, Belgium. joanna.vermeij@zna.be
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't